Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Puja P. Khanna"'
Autor:
Dinesh Khanna, Cristina Padilla, Lam C. Tsoi, Vivek Nagaraja, Puja P. Khanna, Tracy Tabib, J. Michelle Kahlenberg, Amber Young, Suiyuan Huang, Johann E. Gudjonsson, David A. Fox, Robert Lafyatis
Publikováno v:
JCI Insight, Vol 7, Iss 17 (2022)
BACKGROUND Systemic sclerosis (SSc) is an autoimmune, connective tissue disease characterized by vasculopathy and fibrosis of the skin and internal organs.METHODS We randomized 15 participants with early diffuse cutaneous SSc to tofacitinib 5 mg twic
Externí odkaz:
https://doaj.org/article/c75c7f302c8941289e403e34846ce699
Autor:
Jasvinder A. Singh, Aseem Bharat, Dinesh Khanna, Cleopatra Aquino-Beaton, Jay E. Persselin, Erin Duffy, David Elashoff, Puja P. Khanna
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-7 (2017)
Abstract Background All published studies of health care utilization in gout have been cross-sectional to date, and most used a patient-reported diagnosis of gout. Our objective was to assess health care utilization and its predictors in patients wit
Externí odkaz:
https://doaj.org/article/30ef59324f724f15831ab9ca25b46186
Autor:
Robert T. Keenan, S. Ohlman, Kenneth G. Saag, Alexander So, Michael H. Pillinger, Puja P. Khanna, Margareta Wikén, Ann‐Charlotte Åkerblad, Erik Sparve, Lisa Osterling Koskinen, Robert Terkeltaub
Publikováno v:
Arthritis & Rheumatology. 73:1533-1542
OBJECTIVE To evaluate the efficacy and safety of anakinra compared to triamcinolone in the treatment of gout flares. METHODS Patients for whom nonsteroidal antiinflammatory drugs and colchicine were not suitable treatments were enrolled in this multi
Publikováno v:
Acr Open Rheumatology
Objective The objective of this study is to assess criteria for gout remission and to use the results to inform criteria for a complete response (CR). Methods A post hoc analysis of two clinical trials was undertaken to determine the frequency with w
Autor:
Dmitry Karayev, Jeffrey S. Warren, Amber Young, Dinesh Khanna, Allan L. Metzger, Kate Homer, Puja P. Khanna, Vivek Nagaraja
Publikováno v:
JCR: Journal of Clinical Rheumatology. 26:115-118
Background/objective The criterion standard for anti-topoisomerase I antibody (anti-topo I antibody) testing in systemic sclerosis (SSc) uses immunodiffusion (ID) techniques, but enzyme-linked immunosorbent assay (ELISA) and multiple-bead technology
Autor:
Mary Ann Zhang, Dinesh Khanna, Tuhina Neogi, Romina Brignardello-Petersen, John FitzGerald, Charles H. King, Nicola Dalbeth, Seoyoung C. Kim, Leslie R. Harrold, Marat Turgunbaev, Tarun Sharma, David B. Mount, Benjamin J Smith, Aleksander Lenert, Shiv T Sehra, Anila Qasim, Ted R. Mikuls, Michael Toprover, Abhijeet Danve, Amy S. Turner, Linan Zeng, Gordon Guyatt, Allan C. Gelber, Puja P. Khanna, Jasvinder A. Singh, Ann K. Rosenthal, Aryeh M. Abeles, Michael H. Pillinger, Gerald Levy, Samuel Poon, Sangmee Sharon Bae, Neil S. Wenger, Caryn A. Libbey, James Edward Sims
Publikováno v:
Arthritis careresearchReferences. 72(6)
To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations.Fifty-seven population, intervention, comparator,
Autor:
Maha Almackenzie, Timothy J. Laing, Carol Dodge, Amber Young, Debra Rizzo, David A. Fox, Dinesh Khanna, Constance A. Mara, Vivek Nagaraja, Puja P. Khanna, W J McCune, Rajaie Namas
Publikováno v:
Quality of Life Research. 27:755-764
Different patient-reported outcome (PRO) measures are used for rheumatic diseases (RD). The aims of this study are—(1) Identify PROMIS® domains most relevant to care of patients with RD, (2) Collect T-Score metrics in patients with RD, and (3) Ide
Autor:
Aseem Bharat, Dinesh Khanna, Jasvinder A. Singh, Erin Lindsey Duffy, Puja P. Khanna, David Elashoff, Jay E. Persselin, Cleopatra Aquino-Beaton
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-7 (2017)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders
Background All published studies of health care utilization in gout have been cross-sectional to date, and most used a patient-reported diagnosis of gout. Our objective was to assess health care utilization and its predictors in patients with physici
Autor:
Nihar Bhakta, Robert T. Keenan, Scott Baumgartner, Alexander So, C. Storgard, Thomas Bardin, Puja P. Khanna, Scott Adler, J. Kopicko, Maple Fung
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, vol. 76, no. 5, pp. 811-820
Annals of the rheumatic diseases, vol. 76, no. 5, pp. 811-820
ObjectivesDetermine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III trial.MethodsPatients on allopurinol ≥300 mg (≥200
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 26(8)
BACKGROUND Management guidelines have identified unmet educational needs in gout patients. Our objective was to develop and pilot test MyGoutCare (MGC©)-a web-based, interactive educational resource for gout patients, tailored to improve knowledge.